key: cord-0707968-hpsfcpln
authors: Graves, Claire E.; Goyal, Neha; Levin, Anna; Nuño, Miriam A.; Kim, Jina; Campbell, Michael J.; Shen, Wen T.; Gosnell, Jessica E.; Roman, Sanziana A.; Sosa, Julie A.; Duh, Quan-Yang; Suh, Insoo
title: ANXIETY DURING THE COVID-19 PANDEMIC: A WEB-BASED SURVEY OF THYROID CANCER SURVIVORS
date: 2022-01-12
journal: Endocr Pract
DOI: 10.1016/j.eprac.2022.01.002
sha: e74198d99e29fa71cc9202eba3deb219164b7d5b
doc_id: 707968
cord_uid: hpsfcpln

OBJECTIVE: Cancer patients and survivors may be disproportionately affected by COVID-19. We sought to determine the effects of the pandemic on thyroid cancer survivors’ healthcare interactions and quality of life. METHODS: An anonymous survey including questions about COVID-19 and the Patient-Reported Outcomes Measurement Information System profile (PROMIS-29, version 2.0) was hosted on the ThyCa:Thyroid Cancer Survivors’ Association, Inc. website. PROMIS scores were compared to previously published data. Factors associated with greater anxiety were evaluated with univariable and multivariable logistic regression. RESULTS: From 5/6/2020 – 10/8/2020, 413 participants consented to take the survey; 378 (92%) met inclusion criteria: diagnosed with thyroid cancer or NIFTP, within the United States, and completing all sections of the survey. Mean age was 53 years; 89% were female, and 74% had papillary thyroid cancer. Most respondents agreed/strongly agreed (83%) that their lives were very different during COVID-19, as was their interaction with doctors (79%). A minority (43%) were satisfied with information from their doctor regarding COVID-19 changes. Compared to pre-COVID-19, PROMIS scores were higher for anxiety (57.8 vs. 56.5, p<0.05) and lower for ability to participate in social activities (46.2 vs. 48.1, p<0.01), fatigue (55.8 vs. 57.9, p<0.01), and sleep disturbance (54.7 vs. 56.1, p<0.01). After adjusting for confounders, greater anxiety was associated with younger age (p<0.01) and change in treatment plan (p=0.04). CONCLUSIONS: During the COVID-19 pandemic, thyroid cancer survivors reported increased anxiety compared to a pre-COVID cohort. To deliver comprehensive care, providers must better understand patient concerns and improve communication about potential changes to their treatment plans.

Drs. Graves, Goyal, Levin, Nuño, Kim, Campbell, Shen, Gosnell, Roman, and Duh 23 have no conflicts of interest. Dr. Sosa is a member of the Data Monitoring Committee of the 24 Medullary Thyroid Cancer Consortium Registry supported by GlaxoSmithKline, Novo Nordisk, 25 Astra Zeneca, and Eli Lilly. Industry research support was received from Exelixis and Eli Lilly. Dr. 26 Suh is a consultant for Prescient Surgical, Medtronic, and Iota Biosciences. 27 28 29 30 31 Corresponding Author: shortages. Early data in the spring of 2020 suggested that an underlying cancer diagnosis may be 79 associated with increased risk of death or intensive care unit (ICU) admission related to COVID-19 80 infection. 1 In a survey by the American Cancer Society Cancer Action Network in March 2020, a third of 81 cancer patients and survivors reported that they were worried about the impact of COVID-19 on their 82 ability to get treatment for their cancer. This concern was particularly acute for those who were in active 83 treatment, of whom nearly half (40%) expressed worry. 2 

Thyroid cancer currently has an estimated lifetime risk of 1.3% in the United States, 3 and its 85 overall incidence increased 3% annually from 1974-2013. 4 While thyroid cancer overall is associated 86 with a high survival rate, survivors require extended surveillance and often lifelong thyroid hormone 87 J o u r n a l P r e -p r o o f supplementation or replacement. Previous studies have shown that thyroid cancer survivors experience 88 physical and psychological challenges associated with reduced self-reported quality of life (QOL) 5 that is 89 similar to, or worse than, patients with lung, colorectal, breast, and prostate cancer. 6, 7 In this study, we 90 sought to understand how the COVID-19 pandemic affected thyroid cancer patients' healthcare 91 interactions and preferences for their care, as well as their QOL and emotional well-being in order to 92 better tailor support to patients during and after the current pandemic and potential future crises. reported anxiety, depression, fatigue, pain interference, physical function, sleep disturbance, and ability 102 to participate in social roles and activities. This measure has been validated in a range of patient 103 populations, including those with cancer. 8, 9 All novel survey questions were developed by a 

Demographic and cancer characteristics are demonstrated in Table 1 . The majority of participants were 176 female (87%) and white (90%), with papillary thyroid carcinoma (74%). Almost all respondents (97%) had 177 undergone surgery, and 70% had undergone radioactive iodine therapy (RAI). At the time of the survey, Table 2 compares characteristics of the study cohort to that of a previously published pre-185 COVID-19 cohort, 6 as well as to national data. 4, 11 Compared to national data, our survey population was 186 older, more predominately female, more white, with a lower percentage of papillary and follicular 187 thyroid carcinoma and higher cancer stage. Characteristics were more similar between our cohort and 188 the pre-COVID-19 survey cohort but had statistically significant differences in all but sex and percent 189 with surgical therapy. (Table 3 ) and multivariable analyses (Table 4) 

The pandemic's effect on anxiety is more difficult to quantify. The increased anxiety reported 265 may be a reflection of more widespread psychological distress from COVID-19 and quarantine across the 266 general population. 14-18 A national study of the general U.S. population in July 2020 found that rates of 267 depression and anxiety had more than doubled in the U.S. compared to pre-pandemic data. 19 A 268 multitude of potential causes of pandemic-related psychological distress have been suggested, including 269 economic instability, fear of COVID infection, and media exposure. 17, 20 The state of uncertainty, a 270 common condition during the pandemic, may have also negatively influenced mental health and QOL 271 during the pandemic. Uncertainty has been shown to initiate a brain-body pathway linking cognitive 272 stress to the autonomic nervous system and a physiologic stress response. 21 This, in turn, has been 273 shown to have negative effects on clinical outcomes of cancer patients. 22 In our sample, younger age 274 was independently associated with increased anxiety -an association that also has been demonstrated 275 in the general U.S. population. 19, 20 While the causes for this trend remain unknown, the pandemic may 276 have particularly affected anxiety and stress among the young due to greater economic vulnerability, 277 increased childcare responsibilities, and/or greater reliance on social or community networks.

A change in treatment plan during COVID was also significantly associated with increased 279 anxiety in our cohort. Our cohort was a mean of 8.3 years from diagnosis and only 20% were undergoing 280 or awaiting treatment. Therefore, the number of affected patients was small (N=45) and may not be 281 generalizable. However, the effects of COVID-19 on the management of thyroid cancer patients are 282 J o u r n a l P r e -p r o o f wide-ranging and have been well-described. [23] [24] [25] At the forefront of these changes was a rapid 283 conversion from office visits to telemedicine in order to limit travel and potential exposure for both 284 patients and healthcare providers. 26, 27 Most participants in our survey reported a change in the way they 285 interacted with their doctors during the pandemic, and most, in fact, preferred to stay away from 286 healthcare facilities. However, fewer than one in five respondents had a discussion with their healthcare 287 provider about how the pandemic had affected or may affect their thyroid cancer treatment, and less 288 than half were satisfied with the amount of information they had received from their doctor's office 

In this survey, thyroid cancer survivors reported decreased sleep disturbance and decreased 309 fatigue compared to pre-COVID-19 QOL data. Again, these differences were small and their clinical 310 significance is unclear, but this finding was surprising, particularly in the setting of exacerbated anxiety, 311 as poor sleep quality is closely linked to depression and anxiety. [31] [32] [33] Fatigue is common among thyroid 312 cancer survivors and persists long after diagnosis and initial treatment. 34 One explanation for the lasting 313 effects is "cancer-related fatigue," which is defined by the National Comprehensive Cancer Network 314 (NCCN) as a "distressing, persistent, subjective sense of physical, emotional, and/or cognitive tiredness 315 or exhaustion related to cancer or cancer treatment that is not proportional to recent activity and 316 interferes with usual functioning." 35 The cause remains unknown, but hypotheses include dysregulation 317 of serotonin, cytokine, hypothalamic-pituitary-adrenal axis, or muscle metabolism/ATP, or circadian 318 rhythm disruption. 36 

There were significant differences in the characteristics of our cohort when compared to 336 national data (Table 2) , including older age, higher female and white predominance, less papillary and 337 more medullary thyroid cancer, higher stage, and higher proportion undergoing radioactive iodine 338 ablation. Our sample may therefore not accurately reflect the views of all thyroid cancer survivors and 339 may overrepresent later-stage patients or those with more aggressive disease when compared to 340 national data. This cohort did have more similar demographic and clinical characteristics to the pre-341 COVID-19 study than to national data, but there remain statistically significant differences in age, race, 342 cancer type, cancer stage, and proportion undergoing radioactive iodine therapy, which may have 343 affected our QOL data. Due to survey anonymity, there is no way to know whether the cohort captured 344 with this survey overlaps with the pre-COVID-19 study's cohort, and therefore differences in answers 345 may not reflect predominately pandemic-related changes. 

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

COVID-19 Pandemic Impact on Cancer Patients and Survivors: Survey Findings Summary Available from

Trends in Thyroid Cancer Incidence and Mortality in the United States

Risk Factors for Decreased Quality of Life in Thyroid Cancer Survivors: Initial Findings from the North American Thyroid Cancer Survivorship Study

Benchmarking health-related quality of life in thyroid cancer versus other cancers and United States normative data

Quality of Life in Thyroid Cancer is Similar to That of Other Cancers with Worse Survival

The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks

PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions

Research electronic data capture (REDCap)--a metadatadriven methodology and workflow process for providing translational research informatics support

Radioactive iodine in differentiated thyroid cancer: a national database perspective

Health-related Quality of Life, depression and anxiety in thyroid cancer patients

Health-related quality of life and disease specific symptoms in long-term thyroid cancer survivors: a study from the population-based PROFILES registry

Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science

The interplay between anxiety, fear, protective behaviors, compassion, and resilience among older adults during a COVID-19 lockdown: a structural equation modeling study

Psychological distress associated with COVID-19 quarantine: Latent profile analysis, outcome prediction and mediation analysis

The Impact of Covid-19 Experiences and Associated Stress on Anxiety, Depression, and Functional Impairment in American Adults

Facing new fears during the COVID-19 pandemic: The State of America's mental health

Post-lockdown depression and anxiety in the USA during the COVID-19 pandemic

Mental distress during the COVID-19 pandemic among US adults without a pre-existing mental health condition: Findings from American trend panel survey

Uncertainty and stress: Why it causes diseases and how it is mastered by the brain

Host factors and cancer progression: biobehavioral signaling pathways and interventions

Thyroid cancer in the age of COVID-19

Thyroid cancer in the Era of COVID-19

Impact of the COVID-19 pandemic on surgery for thyroid cancer in Italy: nationwide retrospective study

Thyroid Cancer and Telemedicine During the COVID-19 Pandemic

Management of differentiated thyroid cancer through nuclear medicine facilities during Covid-19 emergency: the telemedicine challenge

Telemedicine for Cancer Care in the Time of COVID-19

Association of perceived physician communication style with patient satisfaction, distress, cancer-related self-efficacy, and perceived control over the disease

From Fear to Hopelessness: The Buffering Effect of Patient-Centered Communication in a Sample of Oncological Patients during COVID-19

The enemy who sealed the world: effects quarantine due to the COVID-19 on sleep quality, anxiety, and psychological distress in the Italian population

Sleep, physical activity and mental health during the COVID-19 pandemic: complexities and opportunities for intervention

Sleep quality and its association with psychological distress and sleep hygiene: a cross-sectional study among pre-clinical medical students

Fatigue among short-and long-term thyroid cancer survivors: results from the population-based PROFILES registry

NCCN Practice Guidelines for Cancer-Related Fatigue

Cancer-Related Fatigue in Cancer Survivorship

Sleep problems during the COVID-19 pandemic by population: a systematic review and meta-analysis

COVID-19 lockdown and poor sleep quality: Not the whole story